drugset / Trial / NCT05470582
Trial of Tolerability, Safety and Immunogenicity of the Flu-M Vaccine in Children Between 6 Months and 9 Years Old
RandomizedParallel-groupDouble-blindPrevention
Summary
Comparative trial of tolerability, reactogenicity, safety and immunogenicity of the Flu-M vaccine as compared to the Vaxigrip® vaccine in terms of prevention of influenza in children aged 6 months to 9 years (at the time of the first vaccination).
Timeline
- Start
- 2021-02-16
- Primary completion
- 2021-10-29
- Completion
- 2021-12-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Flu-M | Vaccine | 0.25 ml | Intramuscular |
| Subject | Flu-M | Vaccine | 0.5 ml | Intramuscular |
| Comparator | Influenza Virus Vaccine | Vaccine | 0.25 ml | Intramuscular |
| Comparator | Influenza Virus Vaccine | Vaccine | 0.5 ml | Intramuscular |